Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
Hui Zhang, A. Laux, Kurt R. Stenmark, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3852-3852
Open Access | Times Cited: 18

Showing 18 citing articles:

Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms
Hui Zhang, Min Li, Cheng‐Jun Hu, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 914-914
Open Access | Times Cited: 11
The pharmaco-epigenetics of hypertension: a focus on microRNA
Serge Yaacoub, Ammar Boudaka, Ali Alkhatib, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3255-3271
Open Access | Times Cited: 8
Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review
Longfukang Yao, Qianying Liu, Zhixin Lei, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126819-126819
Closed Access | Times Cited: 16
SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner
Xiaozhou Zou, Ting Liu, Zhongjie Huang, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 14
Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
Jaylen Hudson, László Farkas
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12098-12098
Open Access | Times Cited: 26
Revolutionary advances in hypertension detection: Gold nanoparticle-enhanced miRNA-based electrochemical biosensors and emerging nanotechnologies
Parveen Usman, K P Ameya, Durairaj Sekar
Human Gene (2025), pp. 201401-201401
Closed Access
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension
Sue Gu, Khushboo Goel, Lindsay M. Forbes, et al.
Comprehensive physiology (2023), pp. 4295-4319
Open Access | Times Cited: 9
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension
Hui Zhang, Angelo D’Alessandro, Min Li, et al.
Vascular Pharmacology (2023) Vol. 149, pp. 107157-107157
Open Access | Times Cited: 8
Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches
Tatyana Novoyatleva
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8462-8462
Open Access | Times Cited: 5
Roles of microRNA-124 in traumatic brain injury: a comprehensive review
Panxing Wu, He Bao, Xiaoliang Li, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 4
MiR-122-5p as a potential regulator of pulmonary vascular wall cell in idiopathic pulmonary arterial hypertension
Hui Zhao, Ruowang Duan, Qian Wang, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22922-e22922
Open Access | Times Cited: 4
Diagnostic Tools and Biomarkers for Severe Drug Eruptions
Manabu Yoshioka, Yu Sawada, Motonobu Nakamura
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7527-7527
Open Access | Times Cited: 9
Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study
José L. Sánchez-Gloria, Constanza Estefanía Martínez-Olivares, Leonardo del Valle‐Mondragón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12959-12959
Open Access | Times Cited: 3
Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension
Mark O. Dimitry, Youssef Soliman, Reem Ibrahim Elkorashy, et al.
The Egyptian Heart Journal (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 1
MicroRNA in pediatric pulmonary hypertension microRNA profiling to inform disease classification, severity, and treatment response in pediatric pulmonary hypertension
Michael A. Smith, Sam Chiacchia, Jason T. Boehme, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 328, Iss. 1, pp. H47-H57
Closed Access
MicroRNA-124 conducts neuroprotective effect via inhibiting AK4/ATF3 after subarachnoid hemorrhage
Wei Jiang, Qingge Jia, Hongxin Ma, et al.
Experimental Brain Research (2023)
Closed Access
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension
Sue Gu, Khushboo Goel, Lindsay M. Forbes, et al.
Comprehensive physiology (2023) Vol. 13, Iss. 1, pp. 4295-4319
Closed Access
Faculty Opinions recommendation of Diagnostic tools and biomarkers for severe drug eruptions.
Rannakoe Lehloenya
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2021)
Open Access
Page 1

Scroll to top